Detall de la convocatòria


Objectiu de la convocatòria
Recognition for an outstanding interdisciplinary research team for their innovative and meritorious science that has advanced or may advance our fundamental knowledge of cancer, or a team that has applied existing knowledge to advancing the detection, diagnosis, prevention, or treatment of cancer.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
• Carol Barnwell, Ext.: 1670
• Marta López, Ext.: 1576
Convocatòria (URL)
Impresos (URL)
  • Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.
  • Institutions and/or organizations are not eligible to receive the Award.
  • Eligible teams may be comprised of independent faculty-level researchers providing complementary interdisciplinary expertise, each of whom have made separate substantive and quantifiable contributions to the research being recognized.
  • Team members may be working within the same institution or at several institutions. However, if researchers are employed at the same institution, they must possess separate funding and research space.
  • The team research being recognized should reflect work focused on a specific scientific goal that otherwise would not be realized by any single component of the team. Teams comprising academic and industry researchers will be accepted.
  • Documentació
    Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.
    Self-nominations are prohibited
    Nominators must maintain strict confidentiality of their nominations
    Eligible nominations must include the following:
  • A nomination letter written in English (Max: 1,000 words), which comprehensively describes the candidate team's novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of cancer. Letter must specifically outline the team's current research activity and indicate how their collective research across multiple performance sites holds promise for continued substantive contributions to the cancer field. All publications that directly support the mentioned research accomplishments must be referenced within the provided letter.
  • A brief scientific citation (Max: 50 words) highlighting the major scientific contribution(s) justifying the team's nomination.
  • A comprehensive listing of all team members that includes professional title(s), affiliation(s), primary research area(s), and a brief description of each member's substantive and quantifiable contribution(s) to the team.
    See the Program Guidelines and Nomination Instructions for complete details.
  • Arxius